The Uscom share price tumbled today after the company released its quarterly cash report, showing falls across every major category.
The post The Uscom (ASX:UCM) share price plunged 6% today. Here’s why appeared first on The Motley Fool Australia. –
The Uscom share price was down 6% at the close of trade today, at 15.5 cents per share.
A quick take on Uscom
Uscom is a medical technology company engaged in developing, designing, manufacturing, and marketing premium non-invasive cardiovascular and pulmonary medical devices.
The company’s geographical segment includes Australia, Asia, the Americas, Europe, and other regions. It generates maximum revenue from Asia.
The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+; a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology.
Uscom’s financial woes
For the third quarter of FY21, Uscom reported cash receipts of $0.89 million for the period, which is down 53% from $1.91 million in the preceding quarter, and at $4.2 million year-to-date with Q4 trading still ahead.
Uscom’s sales revenue was $0.78 million, down 20% from $0.98 million in the previous quarter. This follows its record growth of cash receipts of 149% and sales revenue of 125% reported in the prior Q2.
For the current quarter, Uscom’s global entity reported a net operating cash outflow of $0.25 million, while for Q2, cash flow was positive at $0.3 million. Uscom remains cash flow positive for the YTD with $2.03 million cash on hand on 31 March.
What did management say?
Uscom executive chair Professor Rob Phillips said that the future looked a lot brighter for the company.
Q3 sales and receipts remain strong but down due to the impact of the Chinese New Year, effecting China activity for 6 weeks, while both European and US activities remained constrained by the pandemic. Hungary has effectively been closed for the quarter and our US team are still unable to attend hospitals and clinics.
However, we remain cash flow positive for the YTD, supported by strong China sales. Going forward, management noted the 18.3% GDP growth in China for the March quarter and look forward to this growth converting into health spending.
Uscom share price snapshot
The Uscom share price has been tumbling for some time. It’s down 11% over the past month, 3% since 2021 began and 26% over the past 12 months.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- Could value finally be emerging for the embattled AMP (ASX:AMP) share price?
- Copper Mountain (ASX:C6C) share price rockets 8% on profit growth
- Bubs (ASX:BUB) share price hits multi-year low but could keep sinking
- Should you invest your super in cryptocurrencies like Bitcoin?
- ASX 200 dips, NIB soars, Perenti rises
Motley Fool contributor Lucas Radbourne-Pugh has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.